WEBCAST: Inter Partes Review (IPR) Proceedings for Biotech and Pharmaceutical Patents: Key Strategies for US Patent Owners
Date/Time Wednesday, June 17, 2015 at 6:00 PM GMT/UTC
Duration 60 Minutes
Description
Handout Materials
Presentation Slides
Royzman Bio
Zalesin Bio
Presented and Sponsored by Patterson Belknap Webb & Tyler LLP

This webcast will cover what in-house counsel need to know about inter partes reviews (IPRs) for US biotech/pharmaceutical patents. The speakers will include a discussion of the latest trends in IPRs for biotech/pharmaceutical patents, parallel litigation under the Hatch-Waxman and biosimilars legislation and key strategies to protect these important patents.
Speaker(s)
Irena Royzman, Partner, Patterson Belknap Webb & Tyler LLP
Steven A. Zalesin, Partner, Patterson Belknap Webb & Tyler LLP
Jennifer A. Reda, Assistant General Counsel, Johnson & Johnson
Moderator
None.
Pricing
This archived program is free to view. CLE/CPD is not available.
Notes
CLE/CPD FOR THIS PRESENTATION WAS ONLY AVAILABLE FOR:
Alabama, Alaska, Arizona, Arkansas, British Colombia, California, Colorado, England/Wales, Georgia, Hawaii, Louisiana (pending), Missouri, New Brunswick, New Jersey, New York, Nevada, Pennsylvania, Quebec, Rhode Island, South Carolina, Texas, and Vermont
 
Self-Filing: Alberta, Florida, Idaho, Illinois, Indiana, Iowa, Kentucky, Minnesota, Montana, Nebraska, New Hampshire, New Mexico, North Carolina, North Dakota, Nova Scotia, Oklahoma, Ontario, Oregon, Puerto Rico, Saskatchewan, Tennessee, Utah, Virginia, Washington, West Virginia, Wisconsin, and Wyoming.
More Info